Home > Healthcare > Medical Devices > Therapeutic Devices > Diabetes Care Devices Market

Diabetes Care Devices Market - By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices {Insulin Pumps [Tubed Pumps, Tubeless Pumps], Pens [Reusable, Disposable], Pen Needles}), End-Use (Hospitals, Diagnostic Centers) – Global Forecast, 2024 – 2032

  • Report ID: GMI3250
  • Published Date: Feb 2024
  • Report Format: PDF

Diabetes Care Devices Market Size

Diabetes Care Devices Market size was valued at around USD 46.1 billion in 2023 and is projected to grow at a CAGR of 10% from 2024 to 2032. Diabetes care devices refer to a range of medical devices designed to help individuals with diabetes manage their condition effectively. These devices play a crucial role in monitoring blood glucose levels, administering insulin, and overall diabetes management.
 

Diabetes Care Devices Market

To understand key trends  

The National Diabetes Statistics Report for 2022 by the CDC (Centers for Disease Control) reveals that the prevalence of diabetes has increased, reaching an estimated 37.3 million cases. This accounts for 11.3% of the U.S. population. Among these cases, 28.7 million people have received a diabetes diagnosis, while approximately 8.6 million individuals have diabetes but remain undiagnosed.
 

The growing prevalence of diabetes across the world is the primary factor propelling the diabetes care devices market expansion. The management and control of diabetes is essential to avoid its complications such as kidney failure, gangrene, lower limb amputation, heart attack, blindness, and stroke. Moreover, rapid urbanization has led to an inactive lifestyle, unhealthy diet, and increased stress levels among youth, that are some major factors that result in diabetes, thereby impacting the overall market demand.
 

Diabetes Care Devices Market Trends

The integration of smart technology into insulin delivery devices, such as insulin pens and pumps, has significantly transformed the landscape of diabetes management. This innovation not only enhances the convenience for individuals with diabetes but also improves the overall efficacy of treatment.
 

  • Smart insulin delivery devices allow for real-time monitoring of insulin usage and glucose levels. This data is often transmitted wirelessly to connected devices such as smartphones or dedicated apps.
     
  • Healthcare providers can remotely access this data, enabling them to closely monitor patients' glucose patterns, identify trends, and make informed adjustments to treatment plans without requiring frequent in-person visits.
     
  • Patients can actively engage in their diabetes management through user-friendly interfaces on connected devices. These interfaces often provide visual representations of glucose trends, medication adherence, and other relevant metrics.
     

Diabetes Care Devices Market Analysis

Diabetes Care Devices Market, By Product, 2021 - 2032 (USD Billion)

To understand key trends  

Based on product, the market is segmented into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is poised for significant growth at a CAGR of 9.9% during the forecast period. The segment is further bifurcated into self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets.
 

  • There was a growing trend toward the adoption of CGM systems for continuous and real-time monitoring of glucose levels. These systems offer more comprehensive data, helping individuals with diabetes and healthcare providers make more informed decisions about diabetes management.
     
  • There was an increasing interest in non-invasive or minimally invasive blood glucose monitoring technologies. Innovations such as transdermal sensors and spectroscopy aimed to provide a more comfortable and convenient alternative to traditional blood sampling methods.
     
  • The use of artificial intelligence and data analytics in blood glucose monitoring devices was becoming more prominent. These technologies enable better analysis of glucose trends, prediction of hypoglycemic or hyperglycemic events, and personalized insights for users.
     

Diabetes Care Devices Market, By End-use (2023)

To understand key trends  

The diabetes care devices market by end-use is categorized into hospitals, ambulatory surgery centers, diagnostic centers, home care, and other end-users. The hospitals segment accounted for around USD 21.4 billion revenue size in 2023.
 

  • Diabetes care devices are increasingly designed to seamlessly integrate with hospital information systems. This integration allows for efficient sharing of patient data between devices and electronic health records, streamlining workflow and improving overall patient care.
     
  • There is a growing trend towards the adoption of point-of-care testing devices for diabetes within hospitals. These devices provide rapid and accurate results, enabling healthcare professionals to make timely decisions and adjustments to treatment plans during patient visits.
     
  • Hospitals are adopting advanced insulin delivery systems that offer precision and flexibility in insulin administration. These systems may include smart infusion pumps or automated insulin delivery devices, allowing for better control and customization of insulin therapy.
     

North America Diabetes Care Devices Market, 2020 - 2032 (USD Billion)

To understand key trends  

North America diabetes care devices market accounted for USD 18.6 billion revenue in 2023 and is predicted to witness substantial market growth.

 

  • Ongoing advancements in technology, including the integration of smart features, connectivity, and data-sharing capabilities, have been prominent in the development of diabetes care devices. This includes continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens.
     
  • Continued innovation in insulin delivery systems, such as smart insulin pens and wearable insulin pumps, aims to improve the convenience and precision of insulin administration. These devices often come with features such as dose calculators and connectivity for data tracking.
     
  • Collaboration between healthcare providers, technology companies, and pharmaceutical manufacturers is on the rise. These partnerships aim to bring together expertise in healthcare delivery, technology development, and pharmaceutical innovation to create comprehensive solutions for diabetes care.
     

Diabetes Care Devices Market Share

The diabetes care devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Becton, Dickinson and Company, Medtronic plc, among others have a notable presence in the market.
 

Diabetes Care Devices Market Companies

Some of the eminent market participants operating in the diabetes care devices industry include:

  • Abbott Laboratories
  • Arkray, Inc.
  • Ascensia Diabetes Care Holding AG
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Bionime Corporation
  • DarioHealth Corp.
  • Dexcom, Inc.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • LifeScan, Inc.
  • Medtronic plc
  • Nova Biomedical, Inc.
  • Novo Nordisk A/S
  • Pendiq GmBH
  • Sanofi
  • Sinocare, Inc.
  • Tandem Diabetes Care Inc.
  • Ypsomed AG

Diabetes Care Devices Industry News:

  • In June 2022, Ascensia Diabetes Care received CE Mark approval for its Eversense E3 Continuous Glucose Monitoring (CGM) System for use in European Union (EU) countries. This approval helped the company to extend its market share especially in European countries.
     
  • In June 2022, Abbott announced launch of bio wearable that help in continuous blood glucose and ketone monitoring in single sensor. This helped the company to enhance its product offerings.
     
  • In May 2022, ARKRAY, Inc., partnered with Rimidi. This partnership provides integration of GLUCOCARD Shine Connex blood glucose monitoring system with Rimidi Platform for blood glucose data for healthcare professionals. This strengthened the company’s offerings as well as provided competitive advantage.
     

Diabetes care devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 - 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Product

  • Blood glucose monitoring devices
    • Self-monitoring blood glucose meters
    • Continuous glucose monitors
    • Testing strips
    • Lancets
  • Insulin delivery devices
    • Insulin pumps
      • Tubed pumps
      • Tubeless pumps
    • Pens
      • Reusable
      • Disposable
    • Pen needles
      • Standard
      • Safety
    • Syringes
    • Other devices

Market, By End-use

  • Hospital
  • Ambulatory surgical centers
  • Diagnostic centers
  • Homecare
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Netherlands
    • Sweden
    • Belgium
    • Denmark
    • Finland
    • Norway
    • Lithuania
    • Latvia
    • Estonia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt
    • Israel
    • Kuwait
    • Qatar
    • Rest of Middle East and Africa

 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global diabetes care devices industry was valued at around USD 46.1 billion in 2023 and is estimated to reach over USD 107.2 billion by 2032 due to the growing prevalence of diabetes across the world.
The blood glucose monitoring devices segment will record 9.9% CAGR during 2024-2032, attributed to the adoption of CGM systems for continuous and real-time monitoring of glucose levels to ensure optimal care to diabetes patients.
North America diabetes care devices industry accounted for USD 18.6 billion in 2023 and is predicted to witness substantial growth through 2032 due to the ongoing advancements in technology, including the integration of smart features, connectivity, and data-sharing capabilities in medical devices.
Abbott Laboratories, Arkray, Inc., Ascensia Diabetes Care Holding AG, B. Braun Melsungen AG, Becton Dickinson and Company, Bionime Corporation, DarioHealth Corp., Dexcom, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Insulet Corporation, LifeScan, Inc., Medtronic plc, Nova Biomedical, Inc., Novo Nordisk A/S, Pendiq GmBH, Sanofi, Sinocare, Inc., Tandem Diabetes Care Inc., and Ypsomed AG.

Diabetes Care Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 21
  • Tables & Figures: 606
  • Countries covered: 37
  • Pages: 257
 Download PDF
Call Us  Download PDF